Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 12 of 12 for “"individualized dosing"”.

  1. MANUFACTURE OF INDIVIDUALIZED DOSING: DEVELOPMENT AND CONTROL OF A DROPWISE ADDITIVE MANUFACTURING PROCESS FOR MELT BASED PHARMACEUTICAL PRODUCTS

    … manufacturing methods for the delivery of individualized dosing and personalized treatments. In recent years, the US Food and Drug Administration (FDA) introduced the Quality by Design (QbD) and Process Analytical Technology (PAT) guidelines to encourage innovation and efficiency in …

    purdue-thes Repository record for MANUFACTURE OF INDIVIDUALIZED DOSING: DEVELOPMENT AND CONTROL OF A DROPWISE ADDITIVE MANUFACTURING PROCESS FOR MELT BASED PHARMACEUTICAL PRODUCTS (opens in a new tab)

  2. Modelo farmacocinético populacional para a prevenção da toxicidade ao sulfato de magnésio em gestantes com pré-eclâmpsia

    … pharmacokinetics model proposes the adoption of individualized dosing schemes of magnesium sulfate based on creatinine and body weight in order to prevent toxicity manifestations.

    brazil-ufrn Repository record for Modelo farmacocinético populacional para a prevenção da toxicidade ao sulfato de magnésio em gestantes com pré-eclâmpsia (opens in a new tab)

  3. Navigating Gaps in ADPKD Research: Early Risk Modeling, Real-World Treatment, and Patient Partnerships

    … the need for side-effect management and individualized dosing to optimize long-term use. Third, an evaluation of patient engagement in the PKD Research Resource Consortium (PKD RRC) explores how structured patient involvement can improve the development and accessibility of research …

    ku Repository record for Navigating Gaps in ADPKD Research: Early Risk Modeling, Real-World Treatment, and Patient Partnerships (opens in a new tab)

  4. Advancing Personalized Medicine in Immunosuppression: Applications of Pharmacokinetics, Pharmacogenomics, and Pharmacomicrobiome

    … to characterize variability and improve individualized dosing. Chapters 1–3 focused on mycophenolate pharmacokinetics in kidney transplant recipients receiving tacrolimus. Intensive plasma and urine sampling was used to characterize mycophenolic acid (MPA), its glucuronide metabolites, …

    umn Repository record for Advancing Personalized Medicine in Immunosuppression: Applications of Pharmacokinetics, Pharmacogenomics, and Pharmacomicrobiome (opens in a new tab)

  5. A radial basis function method for solving optimal control problems.

    … method is applied to a very important drug dosing application: anemia management in chronic kidney disease. A multiple receding horizon control (MRHC) approach based on the RBF-Galerkin method is developed for individualized dosing of an anemia drug for hemodialysis patients. Simulation …

    louisville Repository record for A radial basis function method for solving optimal control problems. (opens in a new tab)

  6. Best practices in sodium bicarbonate and collagen in performance nutrition

    … while maximizing performance benefits. Optimal dosing, timing, use and potential side effects were identified for both supplements. Results: Four articles, comprised of one narrative review and methods-based position stand, one umbrella review of meta-analyses, one small systematic review and …

    texas Repository record for Best practices in sodium bicarbonate and collagen in performance nutrition (opens in a new tab)

  7. Botulinum toxin injections in the face area: mechanism of action, indications, results, complications /

    … is comparatively less robust and requires more individualized patient assessment. In therapeutic applications, botulinum toxin type A represents the first-line treatment for blepharospasm and hemifacial spasm, and plays an established role in the management of facial synkinesis following …

    vilnius Repository record for Botulinum toxin injections in the face area: mechanism of action, indications, results, complications / (opens in a new tab)

  8. Model-Informed Drug Development of Riluzole for Neuroprotection in Acute Spinal Cord Injury: Integrating Pharmacokinetics, Pharmacodynamics, and Clinical Outcomes for Precision Medicine

    … to address clinical heterogeneity and guide individualized treatment based on drug exposure, biomarker response, and recovery profiles. The first objective involved exploring clinical responses to riluzole through comprehensive exploratory data analysis using the RISCIS PK sub-study dataset. …

    houston Repository record for Model-Informed Drug Development of Riluzole for Neuroprotection in Acute Spinal Cord Injury: Integrating Pharmacokinetics, Pharmacodynamics, and Clinical Outcomes for Precision Medicine (opens in a new tab) Embargoed until 2027-05-01

  9. Gene-by-Environment Interaction of Hepatic Xenobiotic Transporter Polymorphisms and Nonalcoholic Steatohepatitis on Drug Disposition and Toxicity

    … pharmacokinetics can provide a better basis for individualized dosing. The purpose behind this study was therefore to utilize a methionine- and choline-deficient (MCD) rodent model to determine the gene-by-environment interactions of hepatic xenobiotic transporter polymorphisms and NASH on the …

    arizona-thes Repository record for Gene-by-Environment Interaction of Hepatic Xenobiotic Transporter Polymorphisms and Nonalcoholic Steatohepatitis on Drug Disposition and Toxicity (opens in a new tab)

  10. Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin: The Basis for Improvement of Personalized Anemia Management

    … of death and cardiovascular events. Therefore, individualized dosing regimen is needed but guidelines for optimal treatment are not available. The main objectives of my dissertation include (1) to develop a quantitative systems pharmacology model of the erythropoietic process to explain …

    buffalo Repository record for Pharmacokinetic and Pharmacodynamic Modeling of Recombinant Human Erythropoietin: The Basis for Improvement of Personalized Anemia Management (opens in a new tab)

  11. Pharmacokinetic modelling of clinically relevant situations in the treatment of hemophilia A and B

    … respect to the patient, who benefits from an individualized dosing regimen rather than a trial and error method, resulting in fewer adverse events and, in many cases, more cost-effective use of factor concentrates. The work presented in this dissertation also explores a variety of factors that …

    waterloo Repository record for Pharmacokinetic modelling of clinically relevant situations in the treatment of hemophilia A and B (opens in a new tab)

  12. Pharmacokinetic and economic implications when switching between hemophilia A treatments

    … units per weight, but this one size fits all dosing mechanism fails to account for pharmacokinetic variability within this population. Appropriate dosing regimens vary by patient and treatment with hemophilia A patients using FVIII concentrates should be individualized from a therapeutic and …

    waterloo Repository record for Pharmacokinetic and economic implications when switching between hemophilia A treatments (opens in a new tab)